Skip to content
healthcare.dev

RECARBRIO

NDC 0006-3856, imipenem anhydrous, cilastatin, and relebactam anhydrous, injection, powder, for solution, from Merck Sharp & Dohme LLC.

Product NDC
0006-3856
Status
Listed
Labeler
Merck Sharp & Dohme LLC
Dosage form
INJECTION, POWDER, FOR SOLUTION
Route
INTRAVENOUS
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
NDA
Application
NDA212819
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/0006-3856 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • IMIPENEM ANHYDROUS500 mg/100mL
  • CILASTATIN500 mg/100mL
  • RELEBACTAM ANHYDROUS250 mg/100mL

Pharmacologic classes

Carbapenems [CS]; Dipeptidase Inhibitors [MoA]; Penem Antibacterial [EPC]; Renal Dehydropeptidase Inhibitor [EPC]; beta Lactamase Inhibitor [EPC]; beta Lactamase Inhibitors [MoA]

Package NDCNDC-11Package
0006-3856-020000638560225 VIAL, SINGLE-DOSE in 1 CARTON (0006-3856-02) / 20 mL in 1 VIAL, SINGLE-DOSE (0006-3856-01)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/be32f468-738b-40df-a425-591e12f65159
  • Medicare Part B payment limits (ASP)

    GET /v1/drugs/asp?ndc=0006-3856

Use it

Look up 0006-3856 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/0006-3856 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 0006-3856. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.